School of Medicine
Showing 201-250 of 535 Results
-
Jenli Dawn Waters, MD
Clinical Assistant Professor, Neurosurgery
BioDr. Waters is a board-certified, fellowship-trained neurosurgeon with the Neurosurgery Program at Stanford Health Care. She is also a clinical assistant professor of neurosurgery in the Department of Neurosurgery at Stanford University School of Medicine.
Dr. Waters specializes in treating a wide range of spinal conditions. These treatments include surgery to relieve numbness or pain related to pressure on the spinal cord and procedures to repair or stabilize the spinal column (spine fusion). Her areas of expertise also include diagnosis and treatment of traumatic brain injury and brain and spinal cancers.
Dr. Waters’ research experience includes helping to develop effective strategies for diagnosing
and treating patients with different neurological cancers, including glioblastomas. As a subspecialty medical expert for spine and neurosurgery, she successfully advocated for insurance coverage of state-of-the-art, minimally invasive approaches to treating epilepsy and brain tumors.
Dr. Waters has published her work in peer-reviewed journals, including the Journal of Neurosurgery and the Journal of Neuro-Oncology. She has also authored and co-authored chapters in numerous books describing neurosurgical techniques and the diagnosis and treatment of various neurological conditions, including brain and spinal cord tumors.
Dr. Waters is a member of the Congress of Neurological Surgeons. -
Ronald D. Watkins
Senior Research Engineer, Rad/Radiological Sciences Laboratory
Current Role at StanfordMy current position is Senior Research Associate in the Radiological Sciences Laboratory and the Molecular Imaging Laboratory in the Department of Radiology at Stanford School of Medicine. I provide hardware, systems, and general technical support for a large group of Faculty members and many students and post docs in the development of advanced medical imaging, metabolic imaging and image-guided interventions. My training background is primarily in RF and electrical engineering. I have spent more than 25 years in the commercial diagnostic imaging industry. Most of the projects I am currently working on involve instrumentation for metabolic imaging using magnetic deuterium imaging. I am also involved in the development of Hybrid systems that combine Positron Emission Tomography and Magnetic Resonance imaging. Other projects I am involved in use focused ultrasound for neuro-stimulation or drug delivery via blood brain barrier. I also provide RF coil design and support for small animal imaging and various research studies. I have ongoing collaborations with many other medical research institutes and Universities around the world. I currently have 45 issued US patents, and 100 pear reviewed publications.
-
Kathleen Watson
Instructor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Robert Waymouth
Robert Eckles Swain Professor of Chemistry and Professor, by courtesy, of Chemical Engineering
BioRobert Eckles Swain Professor in Chemistry Robert Waymouth investigates new catalytic strategies to create useful new molecules, including bioactive polymers, synthetic fuels, and sustainable plastics. In one such breakthrough, Professor Waymouth and Professor Wender developed a new class of gene delivery agents.
Born in 1960 in Warner Robins, Georgia, Robert Waymouth studied chemistry and mathematics at Washington and Lee University in Lexington, Virginia (B.S. and B.A., respectively, both summa cum laude, 1982). He developed an interest in synthetic and mechanistic organometallic chemistry during his doctoral studies in chemistry at the California Institute of Technology under Professor R.H. Grubbs (Ph.D., 1987). His postdoctoral research with Professor Piero Pino at the Institut fur Polymere, ETH Zurich, Switzerland, focused on catalytic hydrogenation with chiral metallocene catalysts. He joined the Stanford University faculty as assistant professor in 1988, becoming full professor in 1997 and in 2000 the Robert Eckles Swain Professor of Chemistry.
Today, the Waymouth Group applies mechanistic principles to develop new concepts in catalysis, with particular focus on the development of organometallic and organic catalysts for the synthesis of complex macromolecular architectures. In organometallic catalysis, the group devised a highly selective alcohol oxidation catalyst that selectively oxidizes unprotected polyols and carbohydrates to alpha-hyroxyketones. In collaboration with Dr. James Hedrick of IBM, we have developed a platform of highly active organic catalysts and continuous flow reactors that provide access to polymer architectures that are difficult to access by conventional approaches.
The Waymouth group has devised selective organocatalytic strategies for the synthesis of functional degradable polymers and oligomers that function as "molecular transporters" to deliver genes, drugs and probes into cells and live animals. These advances led to the joint discovery with the Wender group of a general, safe, and remarkably effective concept for RNA delivery based on a new class of synthetic cationic materials, Charge-Altering Releasable Transporters (CARTs). This technology has been shown to be effective for mRNA based cancer vaccines. -
Emmanuelle Weber
Physical Science Research Scientist, Rad/Radiological Sciences Laboratory
BioDr. Emmanuelle Weber is a physicist who earned her Ph.D. specializing in the development and applications of the Dynamic Nuclear Polarization (DNP) method, integrating NMR and EPR spectroscopy in her research. She has joined Dr. McNab’s group, where she is focusing on brain diffusion MRI, deep learning for medical image processing, and augmented reality for neuronavigation.
-
Kenneth Weber, DC, PhD
Senior Research Scientist, Anesthesia - Adult Pain Medicine
BioDr. Weber's research seeks to develop markers of pain and sensorimotor function using machine-learning and advanced brain, spinal cord, and musculoskeletal magnetic resonance imaging. Dr. Weber aims to use these techniques to better understand the neuropathology of pain and neurological conditions and discover more effective treatments and preventative strategies.
-
Whitney Weber
Postdoctoral Scholar, Infectious Diseases
BioWhitney is a postdoctoral scholar in the laboratory of Dr. Joelle Rosser at Stanford University investigating the impacts of climate change on arbovirus infection acquisition in a mother-child human cohort in Indonesia. She recently completed her PhD in 2024 focused in viral immunology in the laboratory of Dr. Daniel Streblow at Oregon Health and Science University. She has 4+ years of experience focused in antibody-mediated immunity to emerging pathogenic alphaviruses. Her dissertation research focused on characterizing cross-reactive immunity in the context of alphavirus infection and vaccination in an effort to develop cross-protective alphavirus vaccines. Her post-bacc work included 2+ years of research experience in HIV immunology studying the mechanism of HIV cure and evaluating therapeutics in NHP. Her long-term research and career interests are rooted in studying the mechanisms of viral emergence, viral surveillance and seroprevalence in various hosts, identifying cross-reactive immune responses, and developing multivalent vaccine approaches for emerging viruses.
-
Mike Tzuhen Wei
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Wei was born and raised in Taipei, Taiwan. He went to Stanford for his undergraduate studies in Biology and earned his medical degree at Weill Cornell Medical College. Unable to stay far from the Bay Area, he returned to Stanford where he completed his residency in internal medicine and subsequently his fellowship in gastroenterology. Dr. Wei has specific interests in colorectal cancer and Barrett’s esophagus surveillance as well as reflux diagnosis and management. He has an interest in endoscopic resection of large polyps and had received training under Dr. Shai Friedland, a world expert in this field. Dr. Wei work focuses on evaluating new tools, technologies and techniques in gastrointestinal cancer surveillance and management. He has been involved in running several trials in endoscopic management of polyps and evaluating artificial intelligence applications in gastroenterology. His work has been published in American Journal of Gastroenterology, Gastrointestinal Endoscopy, Clinical Endoscopy, VideoGIE, and Digestive Diseases and Sciences. He was formerly an Associate Editor for the ACG Case Report Journal (2020-2022) and was on the Board of the Northern California Society of Clinical Gastroenterology. When not in clinic or in endoscopy, Dr. Wei enjoys spending time with his family. He and his family enjoy traveling and exploring new restaurants.
-
Katja Gabriele Weinacht, MD, PhD
Assistant Professor of Pediatrics (Stem Cell Transplantation and Regenerative Medicine)
On Partial Leave from 02/01/2025 To 08/31/2025Current Research and Scholarly InterestsPediatric Hematopoietic Stem Cell Transplantation
DiGeorge Syndrome
Genetic Immune Diseases
Immune Dysregulation -
Ann Weinacker
Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsDr. Weinacker's research interests center around ICU outcomes. Her specific interests include primary graft dysfunction in lung transplant recipients.
-
Alexis Thomas Weiner
Postdoctoral Scholar, Pathology
Current Research and Scholarly InterestsThe planar cell polarity (PCP) signaling pathway polarizes animal cells along an axis parallel to the tissue plane, and in so doing generates long-range organization that can span entire tissues. Although its core proteins and much about their interactions are known, how PCP signaling occurs at a mechanistic level remains fundamentally mysterious. In my current project I will employ novel genetic methods to dissect the logic underlying how cellular asymmetry arises at a molecular level.
-
Eva Weinlander
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsWomen's Health
Mind Body Medicine
Chronic Disease Management -
Julia Weinman
Affiliate, Psych/General Psychiatry and Psychology (Adult)
BioJulia Weinman, MS, MA is a doctoral research affiliate within the Department of Psychiatry and Psychology at the Stanford School of Medicine in the Neuropsychology, Mood and Anxiety Disorder, and Women's Mental Health Lab. She is a doctoral candidate, pursuing her PhD in clinical psychology at Palo Alto University. Her research focuses on interpersonal trauma, empowerment, and post-traumatic growth. Currently, she is working with Dr. Jennifer Keller on the Building Empowerment and Resilience (BEAR) program for adult women with histories of interpersonal trauma.
-
Dana Weintraub
Clinical Associate Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsResearch interests include: 1) Childhood obesity, community-based interventions to increase physical activity 2) Impact of medical-legal collaboration on child and family health.
-
William Weis
Faculty Fellow, Sarafan ChEM-H
Current Research and Scholarly InterestsOur laboratory studies molecular interactions that underlie the establishment and maintenance of cell and tissue structure. Our principal areas of interest are the architecture and dynamics of intercellular adhesion junctions, signaling pathways that govern cell fate determination, and determinants of cell polarity. Our overall approach is to reconstitute macromolecular assemblies with purified components in order to analyze them using biochemical, biophysical and structural methods.
-
Thomas G Weiser, MD, MPH
Clinical Professor, Surgery - General Surgery
BioDr. Thomas Weiser is a general, emergency, and trauma surgeon, and surgical intensivist. He treats and cares for injured patients and those with acute surgical emergencies as well as manages critically ill surgical patients in the Intensive Care Unit.
His research is focused on evaluating the role surgical care plays in the delivery of health services in resource poor settings, in particular low and middle income countries. He is interested in barriers to access and provision of surgical care, the quality of surgical services, and outcomes research as well as the science of implementation, how improvements can be made, and how to strengthen compliance with best practices and change behaviors for the better. He also has an interest in domestic policy as it relates to trauma outcomes, trauma systems, insurance coverage and costs of care, and firearm violence.
Dr. Weiser's projects have focused on the quality of surgical care, strategies for improving the safety and reliability of surgical delivery, and team communications. He works closely with Lifebox, a nonprofit focused on improving surgical and anesthetic safety worldwide, where he was previously the Consulting Medical Officer. Lifebox delivers programs throughout the world in combination with local partners including individual professionals, professional societies, hospitals, other NGOs, and ministries of health. Lifebox works with hospitals in Ethiopia, Liberia, Madagascar, India, Honduras, and Nicaragua, amongst others, to improve care and evaluate the impact of our work. A few programs of particular impact are the distribution of low cost devices to improve the safety of care (including pulse oximeters for the routine monitoring of patients undergoing anesthesia and a new surgical headlight program) and Clean Cut, a surgical infection prevention and control program now being introduced in several countries.
From 2006-2009, he was part of the World Health Organization’s Safe Surgery Saves Lives program where he quantified the global volume of surgery and created, implemented, evaluated, and promoted the WHO Surgical Safety Checklist. He has worked with the WHO and the World Bank, and is completing a Gates Grand Challenge Grant-funded study to improve the safety of cesarean section in Ethiopia.
He is a Program Director at Wellcome Leap where he leads Surgery:Assess/Validate/Expand (SAVE). -
Eric A Weiss, MD, FACEP
Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy focus of research is wilderness medicine, including hypothermia, heat illness, altitude illness, improvised medical care in austere environments and wound care. I also have a strong interest in Disaster Medicine, Travel Medicine and International Health, and Pandemics.
-
Eric L. Weiss, MD, DTM&H
Clinical Associate Professor, Emergency Medicine
Current Research and Scholarly InterestsIgnorance of Hepatitis A Among Travelers (writing up data).Travelers Neglecting to Seek Pre Travel Medicine Advice (writing up data).Fluoroquinolones in the Treatment of Complicated Urinary Tract Infections (new ED study)
